HLS Therapeutics Inc. (OTCMKTS:HLTRF – Get Free Report)’s share price dropped 3.7% during trading on Monday . The stock traded as low as $3.15 and last traded at $3.15. Approximately 5,100 shares were traded during mid-day trading, an increase of 419% from the average daily volume of 983 shares. The stock had previously closed at $3.27.
HLS Therapeutics Price Performance
The stock has a fifty day moving average price of $2.84 and a two-hundred day moving average price of $2.66.
About HLS Therapeutics
HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.
Recommended Stories
- Five stocks we like better than HLS Therapeutics
- 5 Top Rated Dividend Stocks to Consider
- Energy Transfer: Powering Data With Dividends and Diversification
- Dividend Capture Strategy: What You Need to Know
- Qualcomm Stock Is Coiling for a Breakout
- With Risk Tolerance, One Size Does Not Fit All
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
